A lowering effect of soybean β-conglycinin on body fat ratio in human

Therapeutic Research

Volumn 24, Issue 5, 2003, Pages 861-866

  Kambara, Hirofumi ^a   Baba, Toshimitsu ^b   Miyazaki, Chiaki ^b   Hirotsuka, Motohiko ^b   Kito, Makoto ^c  

^a OSAKA RED CROSS HOSPITAL   (Japan)

^b FUJI OIL CO LTD   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

> conglycinin; Body fat ratio; Soybean protein; Triglyceride

Indexed keywords

BETA CONGLYCININ; CHOLESTEROL; PLACEBO; SOYBEAN PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; BODY FAT; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID BLOOD LEVEL; NORMAL HUMAN; SOYBEAN; TABLET; VOLUNTEER;

EID: 0038378781     PISSN: 02898020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Iritani N, Hosomi H, Fukuda H, Tada K, Ikeda H. Soybean protein suppresses hepatic lipogenic enzyme gene expression in Wistar fatty rats. J Nutr 1996;126:380-8.
2. Aoyama T, Kohno M, Saito T, Fukui K, Takamatsu K, Yamamoto T, et al. Reduction by phytasereduced soybean β-conglycinin of plasma triglyceride level of young and adult rats. Biosci Biotechnol Biochem 2001;65:1071-5.
3. Saito T, Kohno M, Tsumura K, Kugimiya W, Kito M. Novel method using phytase for separating soybean β-conglycinin and glycinin. Biosci Biotechnol Biochem 2001;65:884-7.
4. Hayes KC, Pronczuc A, Khosla P. Unsaturated fatty acids, nutritional and physiological significance. British nutrition foundation's task force. London: Chapman & Hall;1992. p. 1-211.
5. Shimamoto T, Komachi Y, Inada H, Doi M, Iso H, Sato S, et al. Trends for coronary heart disease and stroke and their risk factors in Japan. Circulation 1989;79:503-15.